These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32389765)

  • 21. Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes.
    Pop C; Țînț D; Petris A
    Rev Cardiovasc Med; 2021 Sep; 22(3):659-675. PubMed ID: 34565068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Wang W; Huang Q; Pan D; Zheng W; Zheng S
    Int J Cardiol; 2022 Jun; 357():33-38. PubMed ID: 35364137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.
    Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T;
    Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
    Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D
    Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome.
    Olivier CB; Turakhia MP; Mahaffey KW
    Expert Opin Drug Saf; 2018 Mar; 17(3):251-258. PubMed ID: 29363352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology.
    Fukamachi D; Hirayama A; Miyauchi K; Yasuda S; Ogawa H; Ito H; Daida H
    J Cardiol; 2018 Aug; 72(2):113-119. PubMed ID: 29599096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.
    Cannon CP; Gropper S; Bhatt DL; Ellis SG; Kimura T; Lip GY; Steg PG; Ten Berg JM; Manassie J; Kreuzer J; Blatchford J; Massaro JM; Brueckmann M; Ferreiros Ripoll E; Oldgren J; Hohnloser SH;
    Clin Cardiol; 2016 Oct; 39(10):555-564. PubMed ID: 27565018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
    Riesinger L; Strobl C; Leistner DM; Gori T; Akin I; Mehr M; Kellnar A; Mahabadi AA; Bogossian H; Block M; Edelmann F; Sarafoff N; Sibbing D; Ince H; Rassaf T; Mansmann U; Mehilli J; Kääb S; Hausleiter J; Massberg S; Wakili R
    Int J Cardiol Heart Vasc; 2021 Aug; 35():100810. PubMed ID: 34258380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists.
    Vardi M; Debidda M; Bhatt DL; Mauri L; Cannon CP
    Clin Cardiol; 2014 Feb; 37(2):103-7. PubMed ID: 24672813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants.
    Bocchino PP; Angelini F; Toso E
    Rev Cardiovasc Med; 2021 Sep; 22(3):635-648. PubMed ID: 34565066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome-Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
    Limbruno U; De Sensi F; Cresti A; Picchi A; Lena F; De Caterina R
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32824861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Mishra A; Singh M; Acker WW; Kamboj S; Sporn D; Stapleton D; Kaluski E
    J Cardiovasc Pharmacol; 2019 Aug; 74(2):82-90. PubMed ID: 31306367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.
    Dzeshka MS; Brown RA; Capodanno D; Lip GY
    Interv Cardiol Clin; 2017 Jan; 6(1):91-117. PubMed ID: 27886825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis.
    Vitolo M; Javed S; Capodanno D; Rubboli A; Boriani G; Lip GYH
    Expert Rev Cardiovasc Ther; 2020 Sep; 18(9):587-600. PubMed ID: 32772746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey.
    Lane DA; Dagres N; Dan GA; García Seara J; Iliodromitis K; Lenarczyk R; Lip GYH; Mansourati J; Marín F; Scherr D; Potpara TS
    Europace; 2019 Jul; 21(7):1116-1125. PubMed ID: 30874724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation in acute coronary syndrome: patient characteristics and appropriate utilisation of anti-thrombotic therapy in New Zealand (ANZACS-QI 39).
    Ho CY; Nunn C; White J; Kerr A; Lee M
    N Z Med J; 2020 Jul; 133(1519):41-54. PubMed ID: 32777794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?
    Spinthakis N; Farag M; Akhtar Z; Gorog DA
    Curr Vasc Pharmacol; 2018; 16(5):427-436. PubMed ID: 29345587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.